Evidence map›Paper›PMID 32033223›Full record

ArticleNutrients2020

Beneficial Effects of a Low-dose of Conjugated Linoleic Acid on Body Weight Gain and other Cardiometabolic Risk Factors in Cafeteria Diet-fed Rats.

Miguel Z Martín-González, Héctor Palacios, Miguel A Rodríguez, Lluís Arola, Gerard Aragonès, Begoña Muguerza

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Miguel Z Martín-GonzálezUniversitat Rovira i Virgili, Department of Biochemistry and Biotechnology, Nutrigenomics Research Group, 43007 Tarragona, Spain.
Héctor PalaciosUniversitat Rovira i Virgili, Department of Biochemistry and Biotechnology, Nutrigenomics Research Group, 43007 Tarragona, Spain.
Miguel A RodríguezEurecat, Centre Tecnològic de Catalunya, Centre for Omic Sciences (COS), Joint Unit Universitat Rovira i Virgili-EURECAT, Unique Scientific and Technical Infrastructures (ICTS), 43204 Reus, Spain.
Lluís ArolaUniversitat Rovira i Virgili, Department of Biochemistry and Biotechnology, Nutrigenomics Research Group, 43007 Tarragona, Spain.
Gerard AragonèsUniversitat Rovira i Virgili, Department of Biochemistry and Biotechnology, Nutrigenomics Research Group, 43007 Tarragona, Spain.
Begoña MuguerzaUniversitat Rovira i Virgili, Department of Biochemistry and Biotechnology, Nutrigenomics Research Group, 43007 Tarragona, Spain.
Universitat Rovira i Virgili · ESCentre for Omic Sciences · ESTechnological Center of Nutrition and Health · ES

Funding

Generalitat de Catalunya Progama Serra HúnterMinisterio de Ciencia, Innovación y Universidades AGL2013-40707-RMinisterio de Ciencia, Innovación y Universidades AGL2016-77105-R
6 · The paper itself

Abstract

Conjugated linoleic acid (CLA) is a dietary supplement that has been shown to improve obesity. However, some authors have associated high doses of CLA supplementation with liver impairment and insulin resistance. The aim of this study was to assess whether the consumption of low doses of CLA maintained the beneficial effects on the main metabolic disturbances associated with metabolic syndrome (MetS) but prevented the occurrence of non-desirable outcomes associated with its consumption. Male Wistar rats, fed standard or cafeteria (CAF) diet for 12 weeks, were supplemented with three different low doses of CLA in the last three weeks. Both biochemical and H

Indexed as

Dietary SupplementsAnimalsBlood GlucoseCholesterolDietDiglyceridesDisease Models, AnimalInsulinLinoleic Acids, ConjugatedLiverMaleMetabolic SyndromePhospholipidsRatsRats, WistarRisk FactorsBlood GlucoseCholesterolDiglyceridesInsulinLinoleic Acids, ConjugatedPhospholipidsTriglyceridesCLAinsulin resistanceleptinmetabolomicsNAFLDobesity

Identifiers

PMID32033223
PMCPMC7071287
OpenAlexW3004732353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.